Introducing an argonaute-facilitated PCR platform
Abstract
Argonaute proteins are characterized by highly efficient guide DNA/RNA-directed binding to target nucleic acids with high fidelity. Employing this feature, we designed an argonaute-facilitated PCR platform by making use of an argonaute derived from Mesorhizobium japonicum (MejAgo) which does not carry nuclease activity and exposes the 3 end of guide DNA when binding. Each reaction cycle of the MejAgo-PCR platform consists of a denaturing step and a polymerase-mediated extension step, omitting the annealing step required by the traditional PCR. More importantly, MejAgo-PCR could significantly improve the sensitivity of PCR in template detection due to the argonaute-facilitated pairing between guide DNA/primer and template. Thus, an argonaute-facilitated PCR has the potential to be developed as an advanced PCR platform with higher sensitivity and efficiency.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Introducing An Argonaute-facilitated Isothermal Amplification Technology
Feng Gao, Chunyu Han·bioRxiv·Apr 21, 2025
- A programmable pAgo nuclease with universal guide and target specificity from the mesophilic bacterium Kurthia massiliensis
Ekaterina Kropocheva, Anton Kuzmenko, … Andrey V. Kulbachinskiy·Nucleic Acids ResearchPeer-reviewed·Mar 6, 2021
- A programmable pAgo nuclease with RNA target preference from the psychrotolerant bacteria Mucilaginibacter paludis
Wenqiang Li, Yang Liu, … Lixin Ma·bioRxiv·Jun 8, 2021
- The stepwise endonuclease activity of a thermophilic Argonaute protein
- One-pot virus detection based on isothermal amplificationcoupled with temperature-activated argonaute
- Programmable RNA recognition using a CRISPR-associated Argonaute
A. Lapinaite, J. A. Doudna, J. Cate·bioRxiv·Jan 19, 2018